SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 107.69 |
Enterprise Value ($M) | -19.17 |
Book Value ($M) | 228.36 |
Book Value / Share | 1.41 |
Price / Book | 0.47 |
NCAV ($M) | 226.48 |
NCAV / Share | 1.40 |
Price / NCAV | 0.48 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.13 |
Return on Assets (ROA) | -0.57 |
Return on Equity (ROE) | -0.61 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.98 |
Current Ratio | 8.98 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 254.87 |
Assets | 256.75 |
Liabilities | 28.38 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -263.46 |
Net Income | -243.79 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -182.94 |
Cash from Investing | -70.56 |
Cash from Financing | 21.60 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 2.20 | -59.45 | |
13G/A | Berns Paul L | 5.10 | 3.03 | |
13D/A | ARCH Venture Fund XII, L.P. | 19.80 | 0.04 | |
13G | Softbank Group Corp | 4.70 | -1.31 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
419,799 | 928,921 | 45.19 | |
487,096 | 937,996 | 51.93 | |
279,611 | 899,631 | 31.08 | |
(click for more detail) |
Similar Companies | |
---|---|
NBIX – Neurocrine Biosciences, Inc. | NEOG – Neogen Corporation |
NKTX – Nkarta, Inc. | NUVL – Nuvalent, Inc. |
NVAX – Novavax, Inc. |
Financial data and stock pages provided by
Fintel.io